Emerald Health Therapeutics, Inc. (CVE:EMH – Get Free Report) shares traded down 3.8% on Tuesday . The company traded as low as C$0.25 and last traded at C$0.26. 384,329 shares changed hands during mid-day trading, a decline of 40% from the average session volume of 644,760 shares. The stock had previously closed at C$0.27.
Emerald Health Therapeutics Stock Down 3.8 %
The firm’s 50 day simple moving average is C$0.26 and its 200-day simple moving average is C$0.26. The company has a debt-to-equity ratio of 35.45, a current ratio of 2.97 and a quick ratio of 2.61. The company has a market cap of C$52.28 million and a price-to-earnings ratio of -0.37.
About Emerald Health Therapeutics
Emerald Health Therapeutics, Inc, together with its subsidiaries, produces and sells medical cannabis for medical purpose in Canada. The company is also involved in developing natural health products. It offers dried cannabis strains, pre-rolls, and cannabis oil products to its medical patients. The company was formerly known as T-Bird Pharma Inc and changed its name to Emerald Health Therapeutics, Inc in June 2015.
Recommended Stories
- Five stocks we like better than Emerald Health Therapeutics
- ETF Screener: Uses and Step-by-Step Guide
- Charles Schwab Fortifies its Uptrend on EPS Beat
- What Are the U.K. Market Holidays? How to Invest and Trade
- Lockheed Martin Stock Aims for a Fresh All-Time High
- How to Use the MarketBeat Stock Screener
- Beyond the Halving: The Future of Bitcoin Mining Stocks
Receive News & Ratings for Emerald Health Therapeutics Daily - Enter your email address below to receive a concise daily summary of the latest news and analysts' ratings for Emerald Health Therapeutics and related companies with MarketBeat.com's FREE daily email newsletter.